Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: I4BE5F78HR

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-9 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 2 D001249 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1743012
FDA SRS I4BE5F78HR